BIT’s 17th Annual International Congress of
Drug Discovery Science & Technology 2019
Theme: The Disruptive, Integrate, Innovation and Development
Time: November 15-17, 2019
Place: Nanjing, China |
Important Activities |
Scientific Program |
|||||||||
Scientific Program |
||
Stream 2 Master Rostrum |
||
Moderator: Dr. Yinsheng Zhang, Vice President of Pharmaceutical R & D Institute, Chia Tai Tianqing Pharmaceutical Group Co., Ltd, China |
||
Time |
FaceOn |
Speeches and Speakers |
09:00-10:00 |
Opening Ceremony |
|
10:15-10:20 |
Moderator's Introduction |
|
10:20-10:40 |
Nobelist Forum |
|
10:20-10:40 |
|
Title: From Basic Science to Modern Medicine |
10:40-12:20 |
Keynote Forum |
|
10:40-11:00 |
|
Dr. Maode Lai |
11:00-11:20 |
|
Title: Development of CD33 Chimeric Antigen Receptor (CAR) T CellTherapy Against R/R Acute Myeloid Leukemia (AML) Dr. David A. Horne, Vice Provost, Associate Director and Dean of Faculty Affairs, Beckman Research Institute, USA |
11:20-11:40 |
Title: Challenge for Drug Discovery in Japan: Open Innovation and Network |
|
11:40-12:00 |
Title: Advancing Digital Innovation in Pharmaceutical Quality |
|
12:00-12:20 |
|
Title: Protein - Ligand Interactions: Quantum Mechanical Approach |
12:20-12:40 |
High-end Dialogue |
Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2003-2019 BIT Group Global Ltd.